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Abstract. 
 
We found that the magnesium salt of ili-
maquinone, named 201-F, specifically disassembled 
dynamically unstable microtubules in fibroblasts and 
various epithelial cell lines. Unlike classical tubulin-
interacting drugs such as nocodazole or colchicine 
which affect all classes of microtubules, 201-F did not 
depolymerize stable microtubules. In WIF-B–polarized 
hepatic cells, 201-F disrupted the Golgi complex and in-
hibited albumin and alpha1-antitrypsin secretion to the 
same extent as nocodazole. By contrast, 201-F did not 
impair the transport of membrane proteins to the baso-
lateral surface, which was only affected by the total dis-
assembly of cellular microtubules. Transcytosis of two 
apical membrane proteins—the alkaline phosphodi-
esterase B10 and dipeptidyl peptidase IV—was af-
fected to the same extent by 201-F and nocodazole. 
Taken together, these results indicate that only dynam-
ically unstable microtubules are involved in the trans-
port of secretory proteins to the plasma membrane, and 
in the transcytosis of membrane proteins to the apical 
surface. By contrast, stable microtubules, which are not 
functionally affected by 201-F treatment, are involved 
in the transport of membrane proteins to the basolat-
eral surface. By specifically disassembling highly dy-
namic microtubules, 201-F is an invaluable tool with 
which to study the functional specialization of stable 
and dynamic microtubules in living cells.
Key words: microtubules • stability • hepatocyte • 
protein transport • ilimaquinone
 
E
 
pithelial
 
 cells specifically target newly synthesized
secretory and membrane proteins to appropriate
domains of their plasma membrane. Among the
 
mechanisms involved in such vectorial targeting, microtu-
bules (MTs)
 
1
 
 play a fundamental role. They facilitate the
transport of vesicular carriers across significant distances,
participate in their selective delivery to the basolateral or
apical membrane, and are also involved in organelle segre-
gation and localization in the cytoplasm (for review see
Cole and Lippincott-Schwartz, 1995). In hepatocytes in
which the Golgi complex is localized near the apical mem-
brane, MT involvement is even more crucial given that
protein addressing to the apical (biliary) membrane in-
volves an indirect pathway via the basolateral (sinusoidal)
membrane (Bartles et al., 1987).
Within the secretory pathway, MTs are known to play im-
portant roles in mediating the anterograde and retrograde
traffic of vesicular and tubular intermediates between the
ER and the Golgi complex (Lippincott-Schwartz et al.,
1990). There is also a large body of evidence that MTs are
involved in post–Golgi protein trafficking: MTs are re-
quired for efficient transport of membrane proteins to the
apical surface via a direct (see Lafont et al., 1994) or indi-
rect transcytotic pathway (Breitfield et al., 1990; Hun-
ziker et al., 1990). They are also involved in basolateral
targeting of secretory proteins in various cell types includ-
ing hepatocytes, but their role in the transport of mem-
brane proteins to the basolateral surface remains contro-
versial (De Almeida and Stow, 1991; Boll et al., 1991;
Gilbert et al., 1991; Saucan and Palade, 1992; Van der Slu-
ijs et al., 1990; Lafont et al., 1994). One explanation to rec-
oncile these conflicting opinions is that distinct classes of
MTs, possibly with different turnover rates, would be in-
volved in very specialized transport steps.
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1. 
 
Abbreviations used in this paper
 
: AAT, 
 
a
 
1-antitrypsin; IQ, ili-
maquinone; MAP, microtubule-associated protein; MT, microtubule.
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In eukaryotes, cell differentiation is often accompanied
by modifications of MT dynamics. Besides the main subset
of highly dynamic MTs with half-lives of 
 
z
 
10 min, there is
a second population of MTs that can be stabilized for sev-
eral hours (Webster et al., 1987). Although the molecular
basis for such stability is still unknown, stable MTs can be
distinguished from dynamically unstable ones since they
are less sensitive to MT-depolymerizing drugs, and are en-
riched in posttranslationally modified subunits of 
 
a
 
-tubu-
lin (for review see Mac Rae, 1997). These modifications
include enzymatic removal of a single Tyr residue at the
carboxy terminus, generating Glu-tubulin (Kreis, 1987;
Webster et al., 1987), acetylation of the Lys residue in po-
sition 40 (LeDizet and Piperno, 1987; Webster and Borisy,
1989), or more complex modifications such as poly-
glutamylation (Eddé et al., 1990) or polyglycylation (Re-
deker et al., 1994).
A significant effort has been made over the past few
years to understand the biological roles of stable vs. dy-
namic MTs. With respect to cell functions, stable MTs ap-
pear to be specialized; they are involved in fibroblastic mi-
gration (Nagasaki et al., 1994), in localizing vimentin
intermediate filaments in fibroblasts (Gurland and Gun-
dersen, 1995), and in axonal growth (Tanaka et al., 1995).
However, except for one study suggesting involvement of
stable MTs in the traffic of secretory proteins from the ER
to the Golgi in HepG2 cells (Mizuno and Singer, 1994),
there are virtually no data regarding the functions of sta-
ble and dynamic subsets of MTs in vesicular protein traf-
ficking.
Are stable and dynamic MTs involved in distinct steps
of protein trafficking? We addressed this question in he-
patic cells using the polarized WIF-B hybrid cell line,
which has been validated previously as a model to study
hepatic protein transport in vitro (Cassio et al., 1991; Ihrke
et al., 1993; Shanks et al., 1994). The most straightforward
approach would be to depolymerize a subset of MTs in liv-
ing cells selectively and study the functions of the remaining
population. Using drugs that depolymerize MTs by interact-
ing directly with tubulin—such as colchicine or nocoda-
zole—has proven to be unsatisfactory in that dynamically
unstable MTs rapidly disassemble, but stable MTs that are
more resistant are still affected in a time-dependent man-
ner (Khawaja et al., 1988). On the other hand, inhibitors of
protein phosphatases such as okadaic acid (Gurland and
Gundersen, 1993) used to disassemble stable MTs selec-
tively were effective in WIF-B cells, but were too toxic to
allow functional studies. We found an alternative way to
select a subset of MTs in living cells using a drug named
201-F, which disassembled highly dynamic MTs and pre-
served stable MTs for several hours. 201-F is the magne-
sium salt of the sesquiterpene-quinone ilimaquinone (IQ),
which was isolated from the marine sponge 
 
Smenospongia
sp.
 
 (Kondracki and Guyot, 1989). IQ treatment of various
cell lines causes both MT disassembly and MT-indepen-
dent breakdown of the Golgi complex into small vesicles
(Takizawa et al., 1993; Veit et al., 1993). IQ also causes
brefeldin A–like inhibition of vesicular transport without
eliciting retrograde transport (Takizawa et al., 1993). Sur-
prisingly, at concentrations up to 50 
 
m
 
M, IQ had no effect
in isolated rat hepatocytes or WIF-B cells, although cells
were normally sensitive to brefeldin A (L. Barbot, unpub-
 
lished data). The specific properties of 201-F on MTs and
the guarantee that, even though it would revert to IQ in
living cells, we should not observe IQ effects, gave us the
opportunity to study the functional specialization of stable
and dynamic MTs in various steps of protein traffic in the
WIF-B cell line.
 
Materials and Methods
 
Antibodies and Chemicals
 
201-F was prepared by treating IQ with one equivalent of magnesium
ethoxide in tetrahydrofuran. The mixture was stirred for 3 h at room tem-
perature and then filtered. The solvent was removed under reduced pres-
sure to yield the magnesium salt, which was used directly. A concentrated
(5 mM) stock solution of 201-F in ethanol was kept at 4
 
8
 
C.
Native (clone DM1A), acetylated (clone 6-11B-1), and tyrosinated
(clone TUB-1A2) anti-
 
a
 
 tubulin were purchased from Sigma Chemical
Co. (St Louis, MO). Anti-rabbit IgG TRITC conjugates, colchicine, no-
codazole, paclitaxel (Taxol
 
®
 
), saponin, protein A-Sepharose, and protein
G-Sepharose were also purchased from Sigma Chemical Co. NHS–LC–
biotin and streptavidine–agarose beads were from Pierce (Rockford, IL).
Anti-rabbit and anti-mouse IgG FITC conjugates were from Sanofi Diag-
nostics Pasteur (Marnes-la-Coquette, France). Anti-Glu-tubulin poly-
clonal antibodies and monoclonal antibodies to polyglutamylated tubulin
(clone GT335) were kindly provided by Dr. L. Lafanechère (Commisariat
à l’Energie Atomique, Département de Biologie Moléculaire et Struc-
turale, Grenoble, France) and Dr. P. Denoulet (Centre National de la
Recherche Scientifique Unité Propre de Recherche 9065, Collège de
France, Paris), respectively. Monoclonal antibodies against basolateral
B1 and apical B10 hepatocyte membrane proteins were obtained as
previously described (Maurice et al., 1985). Rat 
 
a
 
1-antitrypsin (AAT)
was prepared according to Carlson and Stenflo (1982). Anti-albumin
and antiAAT antibodies were raised in rabbits as previously described
(Biou et al., 1984). The anti-rat DPP IV monoclonal antibody was from
Serotec Ltd. (Kidlington, Oxford, United Kingdom), and that to rat man-
nosidase II (clone 53FC3) was from Berkeley Antibody Co., Inc. (Rich-
mond, CA).
 
Cell Culture and Treatments
 
WIF-B cells were cultured in F12 Coon’s-modified medium (Sigma Chem-
ical Co.) supplemented with 5% FCS (Dutscher, Rungis, France) and
HAT mixture (10
 
2
 
5
 
 M hypoxanthine, 4 10
 
2
 
7
 
 M aminopterine and 1.5 10
 
2
 
5
 
 M
thymidine; Polylabo, Strasbourg, France). Cells were confluent and nor-
mally polarized 8–10 d after plating at a initial density of 7,000 cells/cm
 
2
 
.
Fao cells were cultured in the same medium as WIF-B cells without HAT
mixture. Human pulmonary fibroblasts (kindly provided by Dr. M. De-
houx, Laboratoire de Biochimie A, Hôpital Bichat, Paris, France) and
HeLa cells (kindly provided by Dr. A. Servin, INSERM CJF 94-07,
Châtenay-Malabry, France) were cultured in Dulbecco’s MEM containing
nonessential amino acids and supplemented with 5% FCS. MDCK cells
were grown under a 10% CO
 
2
 
 atmosphere in Dulbecco’s MEM supple-
mented with nonessential amino acids and 10% FCS. Drugs were diluted
in culture medium before use, starting from stock solutions in ethanol (5
mM 201-F) or in dimethyl sulfoxide (10 mM colchicine, nocodazole or
taxol). The working concentration was 10 
 
m
 
M for colchicine, nocodazole,
and taxol. 201-F toxicity on WIF-B cells was measured by trypan blue ex-
clusion after 4 h of treatment with concentrations ranging from 3.1 to 50
 
m
 
M. Cell mortality was 
 
,
 
10% between 3.1 and 25 
 
m
 
M, but 60% at 50 
 
m
 
M.
The maximum morphological effect on albumin scattering was observed
by treating cells for 1 h with 25 
 
m
 
M 201-F. This concentration was used in
all experiments.
 
Western Blot Analysis of 
 
a
 
-tubulin and
Acetylated Tubulin
 
WIF-B cells grown for 8 d in 12-well plates were subjected to MT-acting
drug treatment in F12 culture medium. At the end of the treatments, cells
were rinsed twice in MT-stabilizing buffer (80 mM Pipes, 1 mM MgCl
 
2
 
,
2 mM EGTA, pH 6.9, supplemented with antiprotease mixture: 1 mM
phenylmethylsulfonyl fluoride, 1 mM benzamidine, and 20 
 
m
 
M leupeptin),
and were then extracted with MT-stabilizing buffer containing 0.15% Tri- 
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ton X-100 (37
 
8
 
C for 1 min on a rocking platform) and washed once with
Triton-free buffer. We verified that, in such conditions, cellular MTs were
actually preserved at the morphological level (not shown). Cells were ly-
sed directly in SDS-PAGE sample buffer while extraction media were ad-
justed with 4
 
3
 
 SDS-PAGE sample buffer. Proteins were blotted onto
polyvinyle difluoride membranes, and 
 
a
 
-tubulin or acetylated tubulin
were measured using enhanced chemiluminescence on BioMax films
(Eastman Kodak Co., Rochester, NY) and densitometry. The linearity of
the assay was verified by blotting and revealing tubulin from serial dilu-
tions of cell lysates.
 
Immunofluorescence
 
WIF-B cells were cultured on glass coverslips, and after appropriate treat-
ments were rinsed three times with 0.1 M PBS, pH 7.4, at room tempera-
ture, and were then fixed and permeabilized with methanol at 
 
2
 
20
 
8
 
C for 5
min. To detect small fragments of stable MTs in WIF-B cells treated for
various times with MT-depolymerizing drugs, soluble tubulin was elimi-
nated first to reduce the background fluorescence. For this purpose, cells
were permeabilized in MT-stabilizing buffer (80 mM Pipes, 1 mM MgCl
 
2
 
,
2 mM EGTA, pH 6.9) containing 0.15% Triton X-100 (37
 
8
 
C, 1 min), and
then twice with Triton-free buffer and twice with PBS at room tempera-
ture. Soluble tubulin extraction was also performed with a slightly differ-
ent protocol (0.02% Triton X-100 in MT-stabilizing buffer, 4
 
3 
 
for
 
 
 
1 min
each, 37
 
8
 
C) for high-contrast imaging of Fao, fibroblasts, HeLa, and
MDCK cells treated with MT-depolymerizing agents. All cells were then
fixed with methanol (
 
2
 
20
 
8
 
C, 5 min) except MDCK cells, which were fixed
with 2% paraformaldehyde in MT-stabilizing buffer.
All antibody incubations and washes were performed in PBS. Cells
were incubated with primary antibodies for 1 h at 37
 
8
 
C, washed three
times and incubated (1 h, 37
 
8
 
C) with FITC-conjugated or a mixture of
FITC- and TRITC-conjugated antibodies for single- and double-labeling
experiments, respectively. After three washes, the coverslips were
mounted in Citifluor™ antifadent mounting medium (Citifluor Laborato-
ries, Birmingham, United Kingdom) and examined with a BH-2 micro-
scope (Olympus, Tokyo, Japan) and a CCD camera (491
 
3
 
;
 
 
 
COHU, San
Diego, CA). Confocal microscopy was performed using a TCS 4D laser
scanning microscope (Leica, Heidelberg, Germany).
To assess the stability of MTs that resisted 201-F, a dilution-induced de-
polymerization assay was performed. WIF-B cells were incubated (5
 
3 
 
for
1 min at 37
 
8
 
C) in Hepes-buffered medium (100 mM Hepes, 2 mM MgCl
 
2
 
,
1 mM EGTA, pH 6.9) containing 200 
 
m
 
g/ml saponin, and were then fixed
and processed for the immunofluorescence labeling of acetylated tubulin.
To study the transcytosis of B10 and DPP IV, proteins transiently ex-
pressed at the basolateral membrane were labeled by adding 1:200 (vol/
vol) anti-B10 or anti-DPP IV ascites fluids to the culture medium and in-
cubating cells for 2 h at 37
 
8
 
C. After three washes in PBS, cells were fixed
and permeabilized with methanol (
 
2
 
20
 
8
 
C for 5 min). Incubation with
FITC-conjugated secondary antibodies and subsequent processing was
identical to that described for indirect immunofluorescence.
 
Electron Microscopy
 
After 201-F treatment, cells were rinsed twice in PBS and fixed for 30 min
at room temperature in 0.1 M sodium phosphate buffer (pH 7.4) contain-
ing 3% glutaraldehyde (Sigma Chemical Co.). After scraping, cells were
centrifuged and postfixed in 1% osmium tetroxide solution for 1 h at 4
 
8
 
C.
Dehydrated cells were embedded in Epon (Electron Microscopy Sciences,
Fort Washington, PA), and ultrathin sections were stained with uranyl ac-
etate and lead citrate.
 
Pulse-Chase Experiments
 
For secretion studies, WIF-B cells cultured in 60 mm–diameter dishes were
depleted of both methionine and cysteine in depletion medium (Eagle’s
MEM with nonessential amino acids containing 10 mM calcium lactate and
10 mM Hepes, pH 7.4, and lacking 
 
l
 
-methionine and 
 
l
 
-cysteine). Pulse
labeling was performed for 15 min in the same medium supplemented with
40 
 
m
 
Ci/ml [
 
35
 
S]
 
l
 
-methionine and 
 
l
 
-cysteine mixture (Tran
 
35
 
S-Label; ICN
Pharmaceuticals Inc., Irvine, CA). Cells were washed twice in Tris-
buffered saline (10 mM Tris, 150 mM NaCl, pH 7.4, containing 10 mM
 
l
 
-methionine and 10 mM 
 
l
 
-cysteine), and were then chased for various
times in chase medium (depletion medium containing 10 mM 
 
l
 
-methio-
nine and 10 mM 
 
l
 
-cysteine). When appropriate, drugs were added to the
culture, depletion, pulse, and chase media. In all the experiments after the
chase periods, cells were rinsed twice with Tris-buffered saline and lysed
in 20 mM Tris buffer containing 20 mM NaCl, 1%(wt/vol) sodium deoxy-
cholate, 1%(vol/vol) Triton X-100, 10 mM 
 
l
 
-methionine, and 10 mM
 
l
 
-cysteine, pH 8.0. Chase supernatants and cell lysates were immediately
supplemented with antiprotease mixture, and supernatants were adjusted
to the characteristics of the immunoprecipitation buffer (20 mM Tris/HCl,
pH 8.0, 150 mM NaCl, 1%(vol/vol) Triton X-100, 5 mM EDTA, 10 mM
 
l
 
-methionine, 10 mM 
 
l
 
-cysteine) with 1:10 (vol/vol) of 10
 
3 
 
stock solution.
 
Surface Biotinylation of Proteins
 
Cell surface proteins were covalently labeled with biotin according to
Ihrke (Ihrke et al., 1993). In brief, at the end of a pulse-chase experiment
cells were washed twice with ice-cold PBS containing 0.9 mM CaCl
 
2
 
, 1 mM
MgCl
 
2
 
, and 0.16 mM MgSO
 
4,
 
 pH 7.4, and incubated twice for 20 min at
20
 
8
 
C with NHS-LC-biotin (0.6 mg/ml) in biotinylation buffer (10 mM so-
dium tetraborate, 137 mM NaCl, 3.8 mM KCl, 0.9 mM CaCl
 
2
 
, 1 mM
MgCl
 
2
 
, pH 9.0). The reaction was stopped by adding serum- and biotin-
free culture medium buffered with 20 mM Hepes.
 
Immunoprecipitation
 
Sample clarification was performed twice, either overnight at 4
 
8
 
C, or for 2 h
at room temperature using nonimmune rabbit or mouse serum (80 
 
m
 
l per
sample) and 300 
 
m
 
l of 1:4 suspension of protein A (or protein G)-
Sepharose in immunoprecipitation buffer. After removing the Sepharose
beads, 5–10 
 
m
 
l of immune sera or antibodies were added to samples in the
same conditions. Immune complexes were then precipitated with 100 
 
m
 
l of
protein A (or protein G)-Sepharose, washed three times with immunopre-
cipitation buffer containing 0.1% SDS, and then eluted in SDS-PAGE
sample buffer. Samples were analyzed by SDS-PAGE fluorography using
BioMax films (Eastman Kodak Co.) and quantified by densitometry. In
biotinylation experiments, B1 and B10 proteins were first immunoprecipi-
tated and eluted from protein-G Sepharose beads by boiling in 10% aque-
ous SDS solution, and an aliquot was kept for gel analysis. The eluate was
diluted 1:25 in avidin precipitation buffer (20 mM Tris, 150 mM NaCl,
1%[vol/vol] Triton X-100, 0.2% [wt/vol] BSA, 5 mM EDTA, 10 mM
 
l
 
-methionine, and 10 mM 
 
l
 
-cysteine, pH 8.0). The biotinylated fraction
was then specifically precipitated with 50 
 
m
 
l of streptavidin-agarose bead
suspension and eluted in SDS-PAGE sample buffer.
 
Results
 
201-F Selectively Disassembles Dynamic MTs
 
In WIF-B cells treated for 60 min with 25 
 
m
 
M 201-F, the
immunofluorescence labeling of 
 
a
 
-tubulin showed a mark-
edly disorganized MT network (Fig. 1 
 
b
 
). Treated cells ex-
hibited far fewer MTs than did controls (Fig. 1 
 
a
 
), and a 4-h
treatment did not induce more pronounced breakdown of
MTs than a 1-h treatment as shown in Fig. 1 
 
c
 
. The mor-
phology of the remaining MTs was evocative of stable
MTs, which are very sinuous compared with straight dy-
namic MTs (Kreis, 1987). Thus, we performed immunoflu-
orescence labeling of various posttranslationally matured
forms of 
 
a
 
-tubulin usually found in stable MTs. In both
control and 201-F–treated WIF-B cells, acetylated tubulin
exhibited similar labeling patterns, suggesting that acety-
lated MTs were not affected by 201-F treatment (Fig. 1, 
 
d–
e
 
). By contrast, antibodies to detyrosinated or poly-
glutamylated tubulin did not allow labeling of any MT in
WIF-B cells, but at least one fluorescent spot per cell was
observed, generally localized by the bile canaliculi (Fig. 1,
 
f–g
 
). These observations strongly suggest that acetylation
is the predominant (if not only) posttranslational matura-
tion of tubulin in WIF-B cells, and that 201-F did not disas-
semble this class of MTs. As virtually no detyrosinated tu-
bulin could be observed in WIF-Bs, dynamic MTs were 
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unlikely to be specifically labeled by anti-Tyr-tubulin anti-
body: the images were similar to those obtained by label-
ing 
 
a
 
-tubulin or acetylated tubulin in 201-F-treated cells
(Fig. 1, 
 
b
 
, 
 
e
 
, and 
 
h
 
).
To better understand the effects of 201-F on MTs, we
compared its effect with that of nocodazole. Biochemical
quantifications of 
 
a
 
-tubulin and acetylated tubulin that re-
mained polymerized in MTs during the time course of 201-F
and nocodazole treatments were performed by a Western-
blotting technique after soluble tubulin extraction. No-
codazole was chosen as a reference MT-acting drug that
affects primarily dynamically unstable MTs, and then
gradually causes stable MT depolymerization as the dura-
tion of the treatment increases (Khawaja et al., 1988; Gel-
fand and Bershadsky, 1991). As shown in Fig. 2 
 
a
 
, MT
 
a
 
-tubulin decreased within the first hour of treatment with
both drugs. Beyond 1 h of treatment, MT 
 
a
 
-tubulin con-
tents reached a steady-state at a much higher level in cells
treated with 201-F than that observed with nocodazole,
showing that the subset of 201-F–resistant MTs remained
constant for at least 4 h (Fig. 2 
 
a
 
) as observed morphologi-
cally (see Fig. 1 
 
c
 
). During nocodazole treatment, the MT
contents in acetylated tubulin also decreased, but at a
slower rate than that observed for 
 
a
 
-tubulin (Fig. 2 
 
b
 
).
Similar results were found using 10 
 
m
 
M colchicine (not
shown). These results indicate that, although the overall
population of polymerized tubulin decreased, nocodazole-
resistant MTs were enriched in acetylated tubulin. The
same holds true during 201-F treatment, but to a much
greater extent, as the whole MT subset that resisted 201-F
appeared to contain acetylated tubulin (Fig. 2 
 
b
 
). A mod-
erate increase in tubulin acetylation even occurred in 201-
F–treated cells.
Figure 1. Effect of 201-F on the MT network of WIF-B cells.
Cells grown for 8 d on glass coverslips were treated for 60 min
without (a, d, f, g) or with 25 mM 201-F (b, e, h). 201-F treatment
was extended to 4 h in c. After fixation and permeabilization for 3
min in 2208C methanol, MTs were labeled using antibodies to
a-tubulin (a, b, c), acetylated tubulin (d, e), detyrosinated (f),
polyglutamylated (g), or tyrosinated tubulin (h). After incubation
with FITC-labeled secondary antibodies, coverslips were exam-
ined by confocal microscopy. Bile canaliculi are indicated by ar-
rowheads. Bar, 10 mm.
Figure 2. Quantification of a- and acetylated tubulin in MTs dur-
ing 201-F and nocodazole treatments. WIF-B cells cultured in 12-
well plates were incubated for times ranging between 15 min and
4 h with either 25 mM 201-F (closed symbols), or 10 mM nocoda-
zole (open symbols). At the end of the treatment, soluble tubulin
was extracted in MT-stabilizing buffer containing 0.15% Triton
X-100 (1 min at 378C) followed by one rinse in Triton-free buffer.
Cells were lysed directly using SDS-PAGE sample buffer. Sam-
ple lysates and the corresponding cell extracts were analyzed by
Western blotting. a- and acetylated tubulin were quantified using
enhanced chemiluminescence assay on BioMax films (Eastman
Kodak Co.). Data are expressed relative to the MT contents mea-
sured in untreated cells. Each value is the mean 6 SD of three to
five independent experiments.Poüs et al. Microtubule Stability and Protein Traffic 157
This first set of morphological and biochemical observa-
tions indicates that 201-F has a unique effect on MTs that
is clearly different from that observed with classical MT-
acting drugs such as nocodazole. It seems that 201-F
caused the loss of dynamically unstable MTs, but pre-
served a stable acetylated MT subset for several hours. To
verify this hypothesis, we needed to determine if acety-
lated MTs selected by 201-F treatment were actually sta-
ble, and if there were no dynamic MTs left in 201-F-
treated cells.
To measure MT stability after 201-F treatment, WIF-B
cells were perforated with saponin at 378C to trigger dilu-
tion-induced depolymerization of dynamically unstable
MTs. As shown morphologically in Fig. 3, a and b, acety-
lated MTs resisted depolymerization both in control and
201-F–treated cells, indicating that 201-F treatment actu-
ally preserved the stability of acetylated MTs. This inter-
pretation was confirmed by experiments in which nocoda-
zole was added for 15 or 60 min to the culture medium of
201-F–pretreated cells: immunofluorescent labeling of
a-tubulin (Fig. 3, c–f) indicated that MTs were not further
depolymerized by nocodazole than by a 1-h treatment
with 201-F alone. These results were confirmed using bio-
chemical techniques to quantify MT contents after soluble
tubulin extraction. In this case also, after nocodazole addi-
tion MT a-tubulin, levels remained identical to those mea-
sured with 201-F alone (Fig. 3 g). These experiments also
demonstrate that 201-F caused quantitative disassembly of
dynamic MTs in WIF-B cells as we could not measure any
significant short-term effect of nocodazole on a putative
residual fraction of dynamic MTs.
To make sure that the effects of 201-F are not restricted
to WIF-B cells, we tested various cell types and evaluated
the stability of 201-F-resistant MTs (Fig. 4). The experi-
Figure 3. MTs that resist 201-F treatment
are stable. In a first series of experiments,
control (a) and 201-F–treated cells (b)
were permeabilized using 0.2 mg/ml sapo-
nin in Hepes buffer to trigger dilution-
induced depolymerization of MTs. MTs
were labeled with antibodies to acetylated
tubulin, and were observed by means of
confocal microscopy. Images are the su-
perimposition of four equidistant optical
sections (Dz 5 1.5 mm). Bar, 10 mm. In a
second set of experiments (c–g), cells were
treated with 25 mM 201-F for 1 h. 10 mM
nocodazole was then added into the cul-
ture medium for 15 (d) or 60 min (f). 1-h
201-F and 1h-nocodazole controls are
shown in c and e, respectively. Cells were
then fixed and processed for the immuno-
fluorescent labeling of a-tubulin (c–f).
Soluble  a-tubulin was also extracted with
MT-stabilizing buffer containing 0.15%
Triton X-100. Cellular (C) and extracted
(E) a-tubulin was analyzed by Western
blot (n 5 3; g).The Journal of Cell Biology, Volume 142, 1998 158
ments shown were performed using Fao rat hepatoma
cells from which WIF-B cells originate (Fig. 4, a–c), human
pulmonary fibroblasts (Fig. 4, d–f), HeLa cells (Fig. 4 g-i)
and MDCK cells (Fig. 4 j–l). In the first two columns, cells
were treated without or with 201-F for 1 h, whereas in the
third column, cells were first treated for 1 h with 201-F,
and then nocodazole was added into the culture medium
for 15 min. Cells were then permeabilized in MT-stabiliz-
ing buffer and processed for indirect immunofluorescence
labeling of a-tubulin. As shown in Fig. 4 (b, e, h, k), only a
subset of tortuous MTs resisted 201-F treatment in each of
the cell lines tested. 201-F exhibited similar effects in polar-
ized epithelial cells (MDCK), nonpolarized epithelial cells
(HeLa, Fao), or fibroblasts. Furthermore, as shown above
in WIF-B cells, 201-F–resistant MTs were actually stable as
they resisted nocodazole-induced depolymerization (Fig. 4
c, f, i, l).
Dynamic MTs Mediate the Transport of 
Secretory Proteins
Pulse–chase experiments were used to study the role of
dynamic and stable MTs in the transport of both albumin
(Cassio et al., 1991; Shanks et al., 1994) and AAT, which
are constitutively secreted by WIF-B cells.
Radiolabeling of newly synthesized proteins followed by
a 1-h chase in the presence of increasing concentrations of
201-F showed that the drug inhibited albumin and AAT
secretion in a concentration-dependent manner (Fig. 5 a).
After 1 h of chase, the mean inhibition reached 50% with
25 mM 201-F. Secretion inhibition was not due to a protein
synthesis impairment, as incorporation of radiolabeled
methionine and cysteine into albumin, AAT, and total
proteins was identical in control and 201-F–treated cells
(data not shown). It should also be pointed out that, in
201-F–treated cells, secreted AAT seemed normally glyco-
sylated as the secreted fraction exhibited a molecular mass
identical to that of AAT secreted by control cells (Fig. 5
a). The effect of 201-F on the secretion kinetics of albumin
and AAT was then studied. As shown in Fig. 5 b, secretion
kinetics of both proteins were severely retarded in treated
cells. The inhibitory effect of 201-F resulted in a twofold
increase in the transit times for albumin and AAT secre-
tion as compared with control cells. After a 4-h chase pe-
riod, the secretion yield of albumin and AAT reached 85–
90% in both control and treated cells (data not shown).
Because IQ, from which 201-F originates, is known to
disrupt the Golgi complex and inhibit transport vesicle
budding in vitro, we tested whether the effects of 201-F on
protein secretion resulted from its action on dynamic MTs
or from a side effect that might have altered the integrity
or the function of the Golgi complex.
To test these hypotheses, we first analyzed the effects of
201-F on the structure of the Golgi by means of immuno-
fluorescence and electron microscopy. The Golgi complex
was visualized using antibodies to rat mannosidase II
Figure 4. Dynamic MTs are
selectively depolymerized by
201-F treatment in fibroblas-
tic and epithelial cells. Fao rat
hepatoma cells (a–c), human
pulmonary fibroblasts (d–f),
HeLa cells (g–i), and MDCK
cells (j–l) were treated with-
out (a, d, g, j) or with 25 mM
201-F for 1 h (b–c, e–f, h–i,
k–l). In some cases, 10 mM
nocodazole was added into
the culture medium for 15
min at the end of the 1-h
201-F  treatment (c, f, i, l). Af-
ter three washes with MT-sta-
bilizing buffer, soluble tubulin
was extracted with warm MT-
stabilizing buffer containing
0.02% Triton X-100 (378C,
43  for  1 min). After fixation
(methanol at 2208C for 5
min), cells were processed for
immunofluorescence labeling
of a-tubulin and examined in
a fluorescence microscope.
For MDCK cells, three opti-
cal sections of the same cells
were taken near the basal do-
main (left), across the lateral
domain (middle) and near the
apical domain (right) in each
panel (j–l). Bar, 10 mm.Poüs et al. Microtubule Stability and Protein Traffic 159
(Man II). The Golgi was also readily visualized using anti-
bodies raised against rat serum albumin, which is highly
concentrated in the organelle (Cassio et al., 1991; Shanks
et al., 1994). In double-labeling experiments, the two
markers colocalized in control cells and labeled a region
between nuclei and bile canaliculi (Fig. 6, a and b). In cells
treated with 201-F, the Golgi complex was disrupted, and
both markers were found in organelle fragments that scat-
tered into the cytoplasm while a fraction remained in the
original location by the apical membrane (Fig. 6, c and d).
At the electron microscopy level, individual Golgi stacks
were still identified, and appeared structurally normal ex-
cept for some swelling of the cisternae (Fig. 7). Such a con-
servation of a stacked organization was evocative of an
MT-dependent disruption of the organelle (Rogalski et al.,
1984). Therefore, putative involvement of MT depolymer-
ization in the disruption process was verified in experi-
ments where MTs were stabilized with taxol before 201-F
treatment. In these conditions, Golgi fragmentation was
markedly inhibited (Fig. 6, e–l), indicating that the effect
of 201-F resulted from its action on MTs as shown previ-
ously with other MT-depolymerizing drugs (Thyberg et
al., 1980; Pavelka and Ellinger, 1983; Wehland and Will-
ingham, 1983; Rogalski and Singer, 1984).
To study the involvement of Golgi fragmentation in the
secretory effects of 201-F, we devised experiments in
which WIF-B cells exhibited a normal MT network, but a
disrupted Golgi complex. A way to achieve such condi-
tions was found that involved depolymerization of the MT
network during a 1.5-h treatment with nocodazole to frag-
ment the Golgi complex. Nocodazole was then washed out
to allow reconstitution of the MT network. As shown in
Fig. 8 a, double labeling experiments in which we followed
the time courses of tubulin polymerization and Golgi com-
paction after such nocodazole treatment and washout
showed that the MT network was rebuilt within 20 min af-
ter nocodazole removal, whereas the Golgi remained dis-
rupted for at least 1.5 h. Pulse–chase experiments were
performed in the time window provided by the differential
kinetics of MT repolymerization and Golgi compaction.
Cells were pretreated for 1.5 h with nocodazole. After
drug removal, newly synthesized proteins were pulse-
labeled and chased for 1 h without nocodazole. In such
conditions (Fig. 8 b, column 2) albumin secretion was not
inhibited, as compared with control cells (Fig. 8 b, column
1). This result indicates that Golgi fragmentation was not
responsible for inhibition of albumin secretion observed
when dynamic MTs were depolymerized in 1-h pulse–
chase experiments in the presence of 201-F (Fig. 8 b, col-
umn 5). As proposed by Cole et al. (1996), an alternative
hypothesis would be that, during nocodazole treatment,
the Golgi fragments relocalize near peripheral ER exit
sites to rescue part of the secretory processes via an MT-
independent ER-to-Golgi transport step. When examining
the time-dependent effect of nocodazole on albumin se-
cretion for time periods ranging from 30 min to 12 h, we
observed a twofold decrease in the inhibitory effect of the
drug after 4 h of treatment (Fig. 8 c). Such an evolution of
the inhibition curve might be a good reflection of the relo-
calization phenomenon. This observation would also mean
that, within the 1.5-h treatment that was used in the no-
codazole washout experiments, the relocalization process
was far from being complete, therefore validating our
former conclusion that protein secretion was not inhibited
by Golgi fragmentation.
To rule out the possibility that 201-F might also have af-
fected secretion independently from its effect on dynamic
Figure 5. 201-F inhibits secretion of albumin and AAT in WIF-B
cells. Cells were depleted of methionine and cysteine for 30 min,
and then newly synthesized proteins were radiolabeled for 15 min
with [35S]methionine and cysteine, and were chased for various
times. When appropriate, 25 mM 201-F was added into the deple-
tion, pulse, and chase media. Albumin (circles) and AAT
(squares) were immunoprecipitated from cell lysates and chase
supernatants, and were quantified by SDS-PAGE fluorography
and densitometry. Secretion is expressed as the ratio of secreted
protein to total (secreted plus intracellular) immunoprecipitated
protein to normalize for the variations in the incorporation of
[35S]methionine and cysteine. Secretion inhibition was measured
relative to control values at the last chase time. (a) Effect of 201-F
on albumin and AAT secretion after 1 h of chase. In the upper
graph, the concentration-dependent effect of 201-F is shown. The
lower part of the panel summarizes the data (mean secreted frac-
tions 6 SEM) from four (AAT) to eight experiments (albumin),
and show a sample SDS-PAGE of albumin and AAT immuno-
precipitated from cell lysates (L) and chase supernatants (S). (b)
Secretion kinetics of albumin and AAT in control (open symbols)
and 201-F-treated cells (closed symbols). Kinetic data are fitted
to a three-compartment model for secretion by a nonlinear least-
square method. Transit times are the sum of the reciprocals of the
two rate constants computed from experimental data; they are
the mean 6 SEM of three independent determinations.The Journal of Cell Biology, Volume 142, 1998 160
MTs, we performed experiments in which we combined
nocodazole and 201-F treatments as follows: cells were
pretreated for 4 h with nocodazole to get a residual inhibi-
tory effect on secretion. 201-F was then added into the cul-
ture medium 30 min before protein radiolabeling, and a
1-h chase was performed in the presence of both nocoda-
zole and 201-F (Fig. 8 b, column 4). The control experi-
ment consisted of a 4-h nocodazole pretreatment followed
by a 1-h pulse–chase in the presence of nocodazole (Fig. 8
b, column 3). The fact that 201-F addition did not increase
the inhibitory effect of nocodazole on albumin secretion
means that 201-F effect on secretion did not involve an
MT-independent process. Otherwise, 201-F addition to
nocodazole would have inhibited secretion to the same ex-
tent as 201-F alone (Fig. 8 b, columns 4 and 5, respec-
tively).
This first set of experiments showed that 201-F–sensitive
dynamic MTs were strongly involved in carrying secretory
proteins to the cell surface. Moreover, protein secretion
was inhibited to the same extent when cellular content of
stable MTs was preserved with 201-F (Fig. 8 b, column 5)
or lost by 90% with a 1-h nocodazole treatment (Fig. 8 b,
column 6; see also Fig. 2). This observation means that if
the structure and function of stable MTs was maintained
in 201-F–treated cells, stable MTs did not participate in
the transport of secretory proteins to the cell surface. An-
other argument that also indicates that the effects of 201-F
on secretion are specifically due to dynamic MT depoly-
merization arises from observations we performed in
taxol-treated cells. As shown previously in rat hepatocytes
(Oda and Ikehara, 1982), treatment of WIF-B cells with
10 mM taxol inhibited protein secretion to the same extent
as 10 mM nocodazole in 1-h pulse–chase experiments (Fig.
8 b, columns 7 and 6, respectively). This observation might
indicate that stabilization of dynamic MTs by taxol altered
their involvement in the secretory process, therefore rein-
forcing our previous conclusion that stable MTs did not
participate in protein secretion. In such conditions, the
fact that a combination of taxol and 201-F (Fig. 8 b, col-
umn 8) inhibited secretion to the same extent as taxol
alone (Fig. 8 b, column 7) also argues against any MT-
independent effect of 201-F on secretion.
Stable MTs but not Dynamic MTs Participate in
the Basolateral Transport of Membrane Proteins to
the Cell Surface
In the following experiments, we studied basolateral ex-
pression of two membrane markers: B1 and B10 (Maurice
et al., 1985; Maurice et al., 1988). B1 is expressed at the ba-
solateral surface of hepatocytes, while B10, an alkaline
phosphodiesterase (Scott et al., 1997), is a marker of bile
canaliculi and undergoes indirect addressing via the baso-
lateral membrane in hepatocytes (Maurice et al., 1994)
and in WIF-B cells.
Unlike their well-known role in secretory protein trans-
port, MT involvement in basolateral targeting of mem-
brane proteins remains controversial. As suggested by
Lafont et al. (1994), previous attempts might have failed
because of significant resistance of MTs to depolymerizing
drugs, thereby suggesting that stable MTs are good candi-
dates for mediating this step of protein trafficking. Estab-
lishing the conditions in which all the MTs were disassem-
bled was thus a prerequisite to perform such a study.
These conditions were obtained using colchicine or no-
codazole for 10 h. In the following experiments, colchicine
was preferred to nocodazole because of its irreversible ef-
fect on MTs. As shown in Fig. 9 a (in which cells were per-
Figure 6. 201-F causes MT-
dependent fragmentation of
the Golgi complex. Cells
were treated without (a, b) or
with (c, d) 25 mM 201-F for 1 h,
fixed, and processed for dou-
ble immunofluorescence la-
beling using antibodies to
Man II (a, c) and secretory
albumin (b, d). In a second
set of experiments, cells were
treated with 10 mM taxol for
2 h in serum-free culture me-
dium to stabilize MTs (e, f, i,
j), or with taxol alone for 1 h
and then with a mixture of
taxol and 201-F for one more
hour (g, h, k, l). After fixa-
tion, cells were subjected to
double immunofluorescence
labeling of Man II (e, g) and
albumin (f, h), or that of
a-tubulin (i, k) and albumin
(j, l). All samples were exam-
ined in a confocal micro-
scope. Bar, 10 mm.Poüs et al. Microtubule Stability and Protein Traffic 161
meabilized in an MT-stabilizing buffer to minimize the cy-
toplasmic background fluorescence), a few MTs resisted
depolymerization within the first 2 h of treatment. Small
MT fragments were still observed after 4 h, but complete
breakdown was achieved after a 10-h treatment.
To test whether dynamically unstable MTs are involved
in the transport of B1 and B10 to the basolateral surface,
cells were pretreated with 201-F, and pulse–chase experi-
ments were performed in the presence of the drug. These
experiments were followed by a step of cell surface bioti-
nylation. Even though tight junctions of WIF-B cells are
permeable to the biotinylation reagent (Ihrke et al., 1993),
limiting the chase time to 1 h ensured that most B10 pro-
tein was still expressed at the basolateral surface and was
not undergoing transcytotic transport to the apical mem-
brane (Maurice et al., 1994). Our experiments showed that
after 201-F treatment, B1 and B10 proteins were normally
inserted into the plasma membrane (Fig. 9 b), indicating
that dynamic MTs did not participate in the basolateral
transport of these two proteins.
By contrast, complete disassembly of dynamic and sta-
ble MTs by 10-h colchicine treatment inhibited basolateral
membrane expression of both B1 and B10 proteins (Fig. 9
b). This set of experiments suggested that the transport of
membrane proteins to the basolateral domain of WIF-B
cells involved stable MTs. This result would also indicate
that, as hypothesized earlier, 201-F did not impair the
function of stable MTs in terms of protein transport, and
would therefore validate our conclusion about the lack of
involvement of stable MTs in the transport of secretory
proteins to the cell surface.
Dynamic MTs Mediate the Transcytosis of B10
and DPP IV
Apical proteins undergo indirect addressing via the basolat-
eral membrane in both hepatocytes and WIF-B cells (Mau-
rice et al., 1994; Ihrke et al., 1998). The transcytotic trans-
port of apical proteins in hepatocytes has already been
shown to depend on the integrity of the MT network (Hem-
ery et al., 1996). To study the functional specialization of
MTs in transcytosis, newly synthesized B10 and DPP IV
transiently expressed at the basolateral membrane were
continuously tagged by adding specific antibodies to the cul-
ture medium for 2 h in control and 201-F–treated cells. In
control cells, both proteins were highly concentrated in the
apical membranes (Fig. 10, a and b ). When cells were
treated with 201-F, transcytosis was partly inhibited with a
reduction in the relative fluorescence in apical membranes
and an increase in basolateral labeling of both proteins. A
significant amount of both proteins was also observed inside
the cell, suggesting that 201-F did not inhibit the internaliza-
tion from the basolateral membrane (Fig. 10, c and d ).
These experiments indicate that dynamic MTs were neces-
sary for transcytotic transport of apical proteins, and that
stable MTs unaffected by 201-F treatment could not achieve
normal transcytosis from the basolateral to the apical sur-
face. When cells were treated overnight with colchicine, bile
canaliculi were very difficult to identify morphologically
(not shown), as they tended to collapse (Durand-Schneider
et al., 1991). Conversely, treatment for 10 h with nocodazole
allowed morphological identification of bile canaliculi. In
such conditions, transcytosis of DPP IV and B10 was also
partially inhibited, with immunofluorescence labeling on
both basolateral and apical membranes and in a small intra-
cellular fraction (Fig. 10, e–f). Thus, it seems that disassem-
bly of the whole MT network did not inhibit transcytosis of
B10 and DPP IV to a greater extent than selective disassem-
bly of dynamic MTs, suggesting that stable MTs did not par-
ticipate in transcytosis.
Discussion
We found that the magnesium salt of IQ, named 201-F,
disrupted the Golgi complex and inhibited protein secre-
tion in the polarized hepatic cell line WIF-B. 201-F selec-
tively disassembled the highly dynamic network of MTs
without affecting the function of stable MTs. The mecha-
nism by which 201-F causes dynamic MT disassembly is
Figure 7. In 201-F-treated cells, the Golgi fragments are com-
posed of stacked cisternae. The Golgi fragments were visualized
by electron microscopy in control cells (a) or after cells were
treated for 60 min with 201-F (b). Cells were fixed with 3% glu-
taraldehyde in sodium phosphate buffer, post-fixed in 1% osmic
acid, embedded in Epon, and ultrathin sections were counter-
stained with uranyl acetate and lead citrate. In a typical control
cell, the Golgi complex was observed as a condensed organelle
(asterix) located close to the nucleus. 201-F–treated cells exhibited
Golgi fragments with stacked cisternae (arrowheads). Bar, 0.5 mm.The Journal of Cell Biology, Volume 142, 1998 162
not clear. However, in contrast to colchicine or nocoda-
zole, 201-F acts indirectly on MTs. At concentrations up to
100 mM, 201-F did not interfere with tubulin assembly or
disassembly in vitro (D. Guénard, personal communica-
tion). In addition, the effect of 201-F did not involve a sus-
tained increase in cytoplasmic calcium levels (C. Poüs and
L. Combettes, unpublished results). We are currently in-
vestigating the possibility that 201-F affects tubulin phos-
phorylation (Mac Rae, 1997), or that it interferes with the
phosphorylation of structural or motor microtubule-asso-
ciated proteins (MAPs) and/or their binding to MTs (Hi-
rokawa, 1994). The key property of 201-F was its ability to
disassemble dynamic MTs and reproducibly and durably
preserve the stability of acetylated MTs. As judged by the
amount of cellular MTs that resisted 201-F treatment and
the increase we observed in acetylation of cellular MTs,
201-F might also moderately increase the stable MT popu-
lation. Even when used at high concentrations for several
hours, 201-F did not cause disassembly of stable MTs in
contrast to nocodazole. This property was used to study
the specialized functions of stable and dynamic MTs in
mediating various steps of vesicular protein transport.
Our results show that transport of both secretory and
membrane proteins involves distinct stability classes of
MTs. With regard to protein secretion, selective disassem-
bly of highly dynamic MTs by 201-F caused a general slow-
down of albumin and AAT secretion without accumula-
tion in the ER, as the endoglycosidase-H sensitivity of
AAT was identical in control and treated cells (T. Phung-
Koskas, unpublished result). This result, together with the
finding that in hepatic cells, stable MTs are the most prob-
able carriers of albumin from the ER to the Golgi (Mizuno
and Singer, 1994), would indicate that inhibition of protein
secretion resulted from disassembly of dynamic MTs be-
tween the Golgi and the cell surface. In contrast, stable
MTs that resisted 201-F treatment did not participate in
the transport of secretory proteins to the cell surface, but
mediated the transport of B1 and B10 to the basolateral
membrane. These results are in keeping with previous
data showing that secretory and membrane proteins are
transported to the basolateral membrane of hepatocytes in
distinct vesicular carriers (Saucan and Palade, 1994). Al-
though transport of secretory proteins is inhibited by MT-
acting drugs, membrane protein transport does not seem
to involve MTs (De Almeida and Stow, 1991; Boll et al.,
1991; Gilbert et al., 1991; Saucan and Palade, 1992). In
contrast, two studies provided evidence that MTs are in-
volved in the transport of membrane proteins to the baso-
Figure 8. Neither Golgi fragmentation nor a di-
rect effect of 201-F on Golgi membranes are re-
sponsible for the inhibitory effect of 201-F on
protein secretion. In a, cells were treated for 1.5 h
with 10 mM nocodazole. Nocodazole was then
washed out to allow reconstitution of the MT
network and compaction of Golgi fragments. At
various times ranging from 0 to 90 min after drug
removal, cells were fixed, processed for double
immunofluorescence labeling of a-tubulin (left
side) and albumin (right side), and examined in a
fluorescence microscope. Bar, 10 mm. b shows the
mean secreted fractions 6 SEM of albumin after
1-h pulse–chase experiments performed in the
following conditions: (1) no treatment; (2) 10 mM
nocodazole pretreatment (1 h) and depletion of
methionine and cysteine in the presence of no-
codazole (30 min), radiolabeling (15 min), and
chase (60 min) without nocodazole; (3) 10 mM
nocodazole pretreatment (4 h), depletion (30
min), pulse labeling (15 min), and chase periods
(60 min) in the presence of nocodazole; (4)10
mM nocodazole pretreatment (4 h), adding 25
mM 201-F during depletion (30 min), pulse label-
ing (15 min), and chase period (60 min); (5–7)
Depletion (30 min), pulse labeling (15 min), and
chase (60 min) in the presence of 25 mM 201-F
(5), 10 mM nocodazole (6), or 10 mM taxol (7);
(8) 10 mM taxol pretreatment (1 h), adding 25
mM 201-F during the depletion (30 min), pulse
labeling (15 min), and chase period (60 min).
Data are the mean 6 SEM of eight (1, 5, 6), four
(2), or three experiments (3, 4, 7, 8). Statistical
comparisons were performed using the Mann and Whitney test. Identical results were obtained with AAT (not shown). c shows the in-
hibition of albumin secretion measured during the time course of nocodazole treatment. Cells were pretreated with 10 mM nocodazole
for times ranging from 0 to 11 h before methionine and cysteine depletion and pulse-labeling with 35S methionine and cysteine in the
presence of the drug. Radiolabeled proteins were chased for 1 h in the presence of nocodazole, and then albumin was immunoprecipi-
tated from chase supernatants and cell lysates. After measurement of the mean secreted fractions of albumin, secretion inhibition was
calculted relative to control values. Data are the mean 6 SEM of three independent determinations.Poüs et al. Microtubule Stability and Protein Traffic 163
lateral surface: basolaterally targeted vesicles were shown
to bind to MTs in vitro (Van der Sluijs et al., 1990), and an
inhibitory effect of nocodazole was observed in strepto-
lysin-O–perforated MDCK cells that provoked total MT
disassembly (Lafont et al., 1994). The best explanation in-
tegrating our results and previous contradictory data is
that stable MTs involved in the transport of membrane
proteins resist depolymerizing drugs for periods that de-
pend on the cell type, and can even exceed an entire inter-
phase (Webster et al., 1987). Overnight colchicine treat-
ment was sufficient to break down all the MTs in WIF-B
cells and, in these conditions, we found that basolateral
transport of B1 and B10 was inhibited.
With regard to transcytosis, the inhibitory effects of 201-F
on apical expression of B10 and DPP IV are explained by
the fact that transcytosis can be inhibited by MT-acting
drugs in hepatocytes (Durand-Schneider et al., 1991; Hem-
ery et al., 1996) and in other epithelial cells (Breitfield et al.,
1990; Hunziker et al., 1990). In MDCK cells, the trans-
cytotic step which has been shown to depend on MTs, corre-
sponds to the movement from basolateral early endosomes
to the apical endosome (Breitfield et al., 1990; Hunziker et
al., 1990). Our observations are in agreement with these
data, as a significant amount of immunolabeled B10 and
DPP IV was found to accumulate inside 201-F–treated cells.
We also observed a large increase in immunofluorescence
at the basolateral membrane of treated cells. Breitfield et
al. (1990) have also observed increased recycling of the
pIgA-receptor at the basolateral membrane, and proposed
that it might result from saturation of the transcytotic
pathway sorting mechanism in basolateral endosomes.
Whatever the mechanism of transcytosis inhibition, func-
tional specialization of MTs is suggested by our data: the
integrity of the dynamic MT network is necessary for tran-
scytosis, but stable MTs did not seem to participate in the
transcytotic transport process. Similar results were ob-
tained in experiments performed in living WIF-B cells, in
which the transcytosis of fluorescent aminopeptidase-N
was arrested by 201-F or nocodazole treatments (M.
Schrader and T.A. Schroer, personal communication).
Such data would also indicate that stable MTs do not par-
ticipate in transcytosis.
Although functional specialization of stable and dy-
namic MTs has already been explored in other fields of
cell biology (see Nagasaki et al., 1994; Gurland and Gun-
dersen, 1995; Tanaka et al., 1995), very few data on their
respective roles in vesicular trafficking are available (Mi-
zuno and Singer, 1994). Functional specialization has been
demonstrated in the basolateral and apical trafficking
pathways of MDCK cells, but was expressed in terms of
molecular motor association, as kinesin and dynein were
both involved in apical transport whereas only kinesin was
involved in basolateral transport (Lafont et al., 1994). The
molecular basis of MT specialization probably has a corre-
sponding molecular specificity for interaction with trans-
port vesicles. By analogy with the differential involvement
of kinesin and dynein in apical and basolateral transport
(Lafont et al., 1994), molecular motors may be good candi-
dates to explain some of the functional differences we ob-
served between stable and dynamic MTs. Other molecular
specificities may also be involved in functional specializa-
tion, such as posttranslational maturation of a-tubulin
Figure 9. Stable MTs are involved in the transport of membrane
proteins to the basolateral surface of WIF-B cells. In a, cells were
treated for times ranging between 1 and 10 h with 10 mM colchi-
cine. To minimize background fluorescence, soluble tubulin was
extracted by permeabilizing cells with 0.15% Triton X-100 in
MT-stabilizing buffer (1 min, 378C). Cells were then fixed, pro-
cessed for immunofluorescence labeling of a-tubulin, and exam-
ined in a fluorescence microscope. Short MTs were still observed
in cells treated for up to 4 h with colchicine (arrowheads), but
could not be detected after 10 h of treatment. When present, bile
canaliculi (b.c) are identified. Bar, 10 mM. b shows the effects of
1-h treatment with 201-F and 10-h treatment with colchicine on
basolateral membrane expression of B1 and B10 proteins. Newly
synthesized proteins were radiolabeled and chased for 1 h in the
presence of 201-F or colchicine, and were then subjected to sur-
face biotinylation. Total B1 and B10 were first immunoprecipi-
tated from cell lysates, and then the biotinylated fractions were
precipitated using streptavidin-agarose. Samples were analyzed
by SDS-PAGE, fluorography and densitometry. Membrane frac-
tions of B1 and B10 are the mean 6 SD of three determinations.The Journal of Cell Biology, Volume 142, 1998 164
and/or variable patterns of MAPs bound to MTs. These
hypotheses are not exclusive as in vitro data suggest that
kinesin binds preferentially to detyrosinated MTs com-
pared with tyrosinated MTs (Liao and Gundersen, 1996).
Even though such data provide a few clues for understand-
ing functional specialization, the actual scheme is probably
not that simple as there may be deeper levels of specializa-
tion among dynamic and stable MT subsets depending on
the nature of the structural and motor MAPs. There is in-
creasing evidence that conventional kinesin and cytoplas-
mic dynein are not the only proteins involved in mem-
brane traffic (Moore and Endow, 1996). It even appears
that different motor proteins might be involved in the
same transport steps (Goodson et al., 1997). In this context,
201-F may be an invaluable tool to study the functions of
stable and highly dynamic MTs at the molecular level. Fur-
thermore, given its original effect, 201-F may be of help in
understanding the mechanisms underlying MT stabiliza-
tion and the regulation of MT stability in living cells.
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